The Toronto-Dominion Bank (NYSE:TD) shares increased 0.35% in last trading session and ended the day at $40.63. TD has a return on assets of 0.70%. The Toronto-Dominion Bank (NYSE:TD) quarterly performance is 0.53%.
The Toronto-Dominion Bank (NYSE:TD) has promoted Nicholas D. Wolf to Assistant Vice President, Store Manager of the Brighton location at 391 Market St. in Brighton, Mass. He is responsible for new business development, consumer and business lending, managing personnel and overseeing the day-to-day operations at the store serving customers throughout the area.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) ended the last trading day at $6.36. Company weekly volatility is calculated as 4.04% and price to cash ratio as 4.29. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) showed a weekly performance of -2.60%.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) announced that the Company participated in the Aegis Growth Conference, took place October 7-9, 2015 in Las Vegas.
On 15 October, Seventy Seven Energy Inc. (NYSE:SSE) shares decreased -1.37% and was closed at $1.44. SSE EPS growth in last 5 year was 25.30%. Seventy Seven Energy Inc. (NYSE:SSE) year to date (YTD) performance is -73.38%.
Seventy Seven Energy Inc. (NYSE:SSE) has scheduled to release its 2015 third quarter operational update and financial results before market open on Wednesday, October 28, 2015. A conference call to discuss the results has been scheduled for the same day at 9:00 a.m. CDT.
The Dixie Group, Inc. (NASDAQ:DXYN) shares decreased -6.19% in last trading session and ended the day at $8.48. DXYN Gross Margin is 24.70% and its has a return on assets of -1.10%. The Dixie Group, Inc. (NASDAQ:DXYN) quarterly performance is -24.29%.
The Dixie Group, Inc. (NASDAQ:DXYN) announced that it will provide an online web simulcast of its third quarter 2015 conference call on Thursday, October 29, 2015. The Company will release its results for the third quarter ended September 26, 2015, before the market opens on October 29, 2015.
INSYS Therapeutics, Inc. (NASDAQ:INSY) caters to the Healthcare space. It has a net profit margin of 13.20% and weekly performance is 3.60%. On the last day of trading company shares ended up at $25.91. INSYS Therapeutics, Inc. (NASDAQ:INSY) distance from 50-day simple moving average (SMA50) is -20.96%.
Insys Therapeutics (NASDAQ:INSY) was upgraded by Zacks from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Market Beat reports.
Leave a Reply